This Company Wants to Rewrite the Future of Genetic Disease—Without Crispr Gene Editing
Tessera Therapeutics is developing a new class of gene editors capable of precisely plugging in long stretches of DNA—something that Crispr can’t do. https://bit.ly/31RPFhg
Security researchers say the group exploited a zero-day in Apple’s operating system to target European government officials over LinkedIn. https://bit.ly/3kmtpoZ
Whether you’re hiking, climbing, or backpacking, here’s how to build a layering system that can handle all that Mother Nature will throw at you. https://bit.ly/3d9dcj6
